These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 8952158)
21. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial. Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF; Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166 [TBL] [Abstract][Full Text] [Related]
22. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis. Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E; Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036 [TBL] [Abstract][Full Text] [Related]
23. Advanced stage (III-IV) Burkitt's lymphoma and B-cell acute lymphoblastic leukaemia in children: kinetic and pharmacologic rationale for treatment and recent results (1979-1983). Murphy SB; Bowman WP; Hustu HO; Berard CW IARC Sci Publ; 1985; (60):405-18. PubMed ID: 3905592 [TBL] [Abstract][Full Text] [Related]
24. A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia. Bassan R; Lerede T; Buelli M; Borleri G; Bellavita P; Rambaldi A; Barbui T Haematologica; 1998 May; 83(5):422-7. PubMed ID: 9658726 [TBL] [Abstract][Full Text] [Related]
25. [Analysis of chemotherapeutic results and prognostic factors of adult acute lymphoblastic leukemia]. Fu MW; Mi YC; Qiu LG; Yu WJ; Lin D; Bian SG; Wang JX Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):435-40. PubMed ID: 19035173 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL. Federico M; Clò V; Brugiatelli M; Carotenuto M; Gobbi PG; Vallisa D; Lombardo M; Avanzini P; Di Renzo N; Dini D; Baldini L; Silingardi V Haematologica; 1998 Sep; 83(9):800-11. PubMed ID: 9825577 [TBL] [Abstract][Full Text] [Related]
27. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
28. [Lymphoblastic lymphoma in children. Poor response in advanced disease with chemotherapy for non-Hodgkin's lymphoma]. Rivera-Luna R; Cárdenas-Cardós R; Martínez-Avalos A; Leal-Leal C; Ruano-Aguilar J; Meza-Coria C; Lanche-Guevara T; de León-Bojorge B Rev Invest Clin; 1994; 46(5):369-75. PubMed ID: 7839017 [TBL] [Abstract][Full Text] [Related]
29. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study. Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R; Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985 [TBL] [Abstract][Full Text] [Related]